Back
ESC Premium Access

Involvement of proprotein convertase subtilisin/kexin type 9 (PCSK9) in aortic valvular calcification

Session: Novel determinants of aortic valve calcification
Topic: Pathophysiology and Mechanisms
Speaker: Doctor P. Poggio (Milan, IT)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Paolo Poggio

Monzino Cardiology Centre, Milan (Italy)
0 follower

5 more presentations in this session

Sortilin is a key driver of fibrocalcific aortic valve disease

Speaker: Doctor F. Schlotter (Mainz, DE)

Access
Abstract
Like
Thumbnail

High extracellular calcium induced valvular calcification through a calcium sensing receptor dependent mechanism

Speaker: Miss H. Issa (Amiens, FR)

Access
Abstract
Like
Thumbnail

Kidney dysfunction is a risk factor for developing aortic stenosis: results from the SCREAM project.

Speaker: Doctor G. Vavilis (Solna, SE)

Access
Abstract
Slides
Like
Thumbnail

Combined predictability of cardiac valvular calcification, protein-energy wasting and inflammation status for cardiovascular mortality in incident haemodialysis patients

Speaker: Assistant Professor H. Takahashi (Toyoake, JP)

Access
Abstract
Slides
Like
Thumbnail

CT valvular calcification in severe aortic stenosis - Which parameter better predicts prognosis?

Speaker: Doctor C. Brizido (Carnaxide, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Novel determinants of aortic valve calcification

Speakers: Doctor P. Poggio, Doctor F. Schlotter, Miss H. Issa, Doctor G. Vavilis, Assistant Professor H. Takahashi...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources